PELLECCHIA, Maria Teresa
 Distribuzione geografica
Continente #
AS - Asia 17.001
NA - Nord America 13.209
EU - Europa 5.015
SA - Sud America 1.317
Continente sconosciuto - Info sul continente non disponibili 635
AF - Africa 161
OC - Oceania 90
Totale 37.428
Nazione #
US - Stati Uniti d'America 12.807
HK - Hong Kong 11.153
SG - Singapore 2.576
IT - Italia 2.140
CN - Cina 1.215
BR - Brasile 975
VN - Vietnam 896
RU - Federazione Russa 538
UA - Ucraina 532
DE - Germania 366
IE - Irlanda 291
FR - Francia 253
KR - Corea 206
CA - Canada 201
TR - Turchia 199
SE - Svezia 196
BD - Bangladesh 184
GB - Regno Unito 177
IN - India 160
FI - Finlandia 140
AR - Argentina 127
MX - Messico 82
JP - Giappone 78
PL - Polonia 64
NL - Olanda 57
AU - Australia 49
CO - Colombia 49
EC - Ecuador 47
AT - Austria 46
IQ - Iraq 46
EE - Estonia 41
ES - Italia 41
ZA - Sudafrica 38
NZ - Nuova Zelanda 37
ID - Indonesia 35
PK - Pakistan 35
CZ - Repubblica Ceca 33
JM - Giamaica 33
VE - Venezuela 33
CL - Cile 26
UZ - Uzbekistan 25
IL - Israele 22
KE - Kenya 22
PE - Perù 22
MA - Marocco 21
CR - Costa Rica 20
PH - Filippine 20
SA - Arabia Saudita 20
PY - Paraguay 18
MY - Malesia 15
LT - Lituania 13
HN - Honduras 12
JO - Giordania 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
BE - Belgio 10
CH - Svizzera 10
EG - Egitto 10
ET - Etiopia 10
UY - Uruguay 10
AZ - Azerbaigian 9
BO - Bolivia 9
LB - Libano 9
OM - Oman 9
DZ - Algeria 8
KZ - Kazakistan 8
DO - Repubblica Dominicana 7
GR - Grecia 7
GT - Guatemala 7
NI - Nicaragua 7
NP - Nepal 7
AL - Albania 6
PA - Panama 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BW - Botswana 5
CY - Cipro 5
KG - Kirghizistan 5
KH - Cambogia 5
PT - Portogallo 5
SC - Seychelles 5
BY - Bielorussia 4
DK - Danimarca 4
GP - Guadalupe 4
LK - Sri Lanka 4
LU - Lussemburgo 4
MN - Mongolia 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
BS - Bahamas 3
CI - Costa d'Avorio 3
GE - Georgia 3
IR - Iran 3
LV - Lettonia 3
Totale 36.725
Città #
Hong Kong 11.133
San Jose 1.670
Ann Arbor 1.422
Singapore 1.238
Ashburn 905
Milan 788
Chandler 733
Princeton 708
Wilmington 667
Jacksonville 665
Dallas 557
Council Bluffs 517
Beijing 319
Dublin 279
Dong Ket 270
Houston 244
Woodbridge 234
The Dalles 223
Ho Chi Minh City 214
Lauterbourg 213
New York 213
Rome 197
Los Angeles 182
Santa Clara 171
Nanjing 156
Izmir 154
Moscow 148
Hanoi 142
Andover 141
Naples 141
Boardman 129
Pellezzano 109
São Paulo 104
Dearborn 93
Salerno 92
Figino 80
Phoenix 75
Buffalo 71
Tokyo 71
Norwalk 61
Montreal 57
Düsseldorf 55
Munich 55
Fairfield 54
Frankfurt am Main 51
Nanchang 49
Changsha 47
Turin 47
Hebei 46
Memphis 46
Warsaw 46
Brooklyn 45
Chicago 45
San Francisco 45
Shenyang 45
Denver 41
Redwood City 41
Atlanta 40
Tallinn 38
Jiaxing 36
Nuremberg 36
Orem 36
Pune 35
Da Nang 34
Rio de Janeiro 33
Seattle 33
Toronto 29
Chennai 28
Haiphong 28
Belo Horizonte 27
Mestre 27
Boston 26
Washington 26
Amsterdam 25
Bologna 22
Brasília 22
London 22
Seoul 22
Brno 21
Johannesburg 21
Mexico City 21
Philadelphia 21
Stockholm 21
Tashkent 21
West Jordan 21
Columbus 20
Curitiba 20
Nairobi 19
Charlotte 18
Kingston 18
Buenos Aires 17
Poplar 17
San Diego 17
Shanghai 17
Turku 17
Auckland 16
Baghdad 16
Guayaquil 16
Helsinki 16
Porto Alegre 16
Totale 27.376
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.217
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.058
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 977
Sex Differences in Parkinson’s Disease: From Bench to Bedside 657
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 616
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 604
Gender differences in microRNA expression in levodopa-naive PD patients 587
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 553
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 541
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 525
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 489
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 405
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 403
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 370
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 366
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 355
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 344
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 336
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 333
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 332
A novel phenotype in an Italian family with a rare progranulin mutation 327
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 285
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 282
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 256
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 229
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 229
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 224
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 220
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 216
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 214
The natural history of multiple system atrophy: A prospective European cohort study 210
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 208
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 204
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 200
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 198
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 196
Postganglionic sudomotor denervation in patients with multiple system atrophy. 194
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 194
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 188
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 188
A critique of the second consensus criteria for multiple system atrophy 184
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 184
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 180
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 179
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 178
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 174
Quitting smoking: An early non-motor feature of Parkinson's disease? 171
Brain anatomical substrates of mirror movements in Kallmann syndrome. 166
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 161
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 161
Increased bilirubin levels in de novo Parkinson's disease 158
“Response to Apomorphine in early Parkinson’s disease”. 157
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 155
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 154
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 154
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 153
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 151
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 150
The relevance of gender in Parkinson's disease: a review 148
Sindromi parkinsoniane 148
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 147
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 147
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 146
Cognitive correlates of “pure apathy” in Parkinson's disease 145
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 143
A genome-wide association study in multiple system atrophy 141
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 141
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 141
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 140
PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts 140
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 139
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 139
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 138
The alpha-synuclein gene in multiple system atrophy 137
Evidenze di efficacia nella riabilitazione della malattia di Parkinson 137
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 137
Gender and non motor fluctuations in Parkinson's disease: A prospective study 135
The accuracy of the arginine growth hormone test in parkinsonism. 133
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 133
Early MRI findings in acquired hepatocerebral degeneration. 130
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 130
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 129
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 128
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 127
Cross-modal connectivity effects in age-related hearing loss 127
SNCA variants are associated with increased risk for multiple system atrophy 126
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 125
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 125
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 125
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 124
Safety and tolerability of growth-hormone therapy in multiple system atrophy 124
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 124
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 124
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 123
A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy 123
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 122
Longitudinal Changes Of Dopamine Transporter In Early-Onset Parkin Disease Measured With 123Fr-Cit Spect 121
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 121
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease 121
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 120
Totale 24.074
Categoria #
all - tutte 115.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.095 0 0 0 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202621.068 3.032 5.189 4.284 697 1.263 609 1.844 420 606 1.158 405 1.561
2026/20272.910 672 399 1.052 787 0 0 0 0 0 0 0 0
Totale 37.428